GET 73

Drug Profile

GET 73

Alternative Names: Gamma hydroxybutyric acid analogue; GET-73; GHB analogue

Latest Information Update: 21 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator CT Laboratories
  • Class Anilides; Drug withdrawal therapies; Fluorobenzenes; Hydroxybutyrates; Neuroprotectants; Obesity therapies; Small molecules
  • Mechanism of Action Metabotropic glutamate receptor 5 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Alcoholism

Most Recent Events

  • 21 Mar 2017 GET 73 is still in phase I/II trials for Alcoholism in USA
  • 01 Oct 2014 Phase-I/II clinical trials in Alcoholism (For alcohol dependence/alcohol withdrawal) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top